“The Molson” is a low-barrier, peer-staffed, supervised consumption site located in Vancouver, Canada. In addition to overdose response, this site offers drug checking and a colocated injectable hydromorphone treatment program, and it distributes tablet and liquid hydromorphone to service users at high risk of overdose. Our evaluation suggests benefits of this program in creating service continuums and preventing overdose deaths. From September 2017 to August 2019, the site had 128 944 visits, reversed 770 overdoses, and had no overdose deaths.
Michelle Olding MPH, Andrew Ivsins PhD, Samara Mayer MPH, Alex Betsos MSc, Jade Boyd PhD, Christy Sutherland MD, Coco Culbertson, Thomas Kerr PhD, and Ryan McNeil PhD
American Journal of Public Health, April 16, 2020